| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
ABC3 – Disclosure of Conflict of Interest
|
|
|
2015
|
24 |
S3 |
p. S76-S77
2 p.
|
artikel
|
| 2 |
Abstract Presenters
|
|
|
2015
|
24 |
S3 |
p. S16-S17
2 p.
|
artikel
|
| 3 |
Abstracts List
|
|
|
2015
|
24 |
S3 |
p. S82-S85
4 p.
|
artikel
|
| 4 |
Author index
|
|
|
2015
|
24 |
S3 |
p. S78-S81
4 p.
|
artikel
|
| 5 |
Award
|
|
|
2015
|
24 |
S3 |
p. S6-
1 p.
|
artikel
|
| 6 |
BP103 ELECTROCHEMOTHERAPY IN THE TREATMENT OF CUTANEOUS METASTASES FROM BREAST CANCER: A MULTICENTER COHORT ANALYSIS
|
Agresti, Roberto
|
|
2015
|
24 |
S3 |
p. S57-
1 p.
|
artikel
|
| 7 |
BP129 INSULIN RESISTANCE (IR) AND PROGNOSIS OF METASTATIC BREAST CANCER (MBC) PATIENTS
|
Provinciali, Nicoletta
|
|
2015
|
24 |
S3 |
p. S66-
1 p.
|
artikel
|
| 8 |
BP52 IS THERE A DIFFERENT TREATMENT RESPONSE BETWEEN VISCERAL AND NON-VISCERAL METASTATIC BREAST CANCER: A SYSTEMATIC LITERATURE REVIEW OF REGISTRATION TRIALS
|
Würstlein, Rachel
|
|
2015
|
24 |
S3 |
p. S39-
1 p.
|
artikel
|
| 9 |
BP38 METASTATIC BREAST CANCER IN CANADA: WAITING FOR TREATMENT
|
Chari, Niya
|
|
2015
|
24 |
S3 |
p. S34-S35
2 p.
|
artikel
|
| 10 |
Breast Cancer Patient Advocacy Programme
|
|
|
2015
|
24 |
S3 |
p. S8-
1 p.
|
artikel
|
| 11 |
Chairs and Panel Members
|
|
|
2015
|
24 |
S3 |
p. S6-S7
2 p.
|
artikel
|
| 12 |
Editorial Board
|
|
|
2015
|
24 |
S3 |
p. ii-
1 p.
|
artikel
|
| 13 |
Endorsement and Auspices
|
|
|
2015
|
24 |
S3 |
p. S4-
1 p.
|
artikel
|
| 14 |
General Information
|
|
|
2015
|
24 |
S3 |
p. S2-S3
2 p.
|
artikel
|
| 15 |
High Patronage
|
|
|
2015
|
24 |
S3 |
p. S4-
1 p.
|
artikel
|
| 16 |
IN31 ADDRESSING THE EMOTIONAL NEEDS OF PATIENTS WITH ADVANCED METASTATIC BREAST CANCER
|
Shockney, Lillie D.
|
|
2015
|
24 |
S3 |
p. S32-
1 p.
|
artikel
|
| 17 |
IN27 ADVANCED BREAST CANCER: IS THERE AN OPTIMAL SEQUENCE OF SYSTEMIC ANTICANCER AGENTS?
|
Francis, Prudence A.
|
|
2015
|
24 |
S3 |
p. S31-
1 p.
|
artikel
|
| 18 |
IN26 BIOPSY, REBIOPSY AND DEALING WITH DISCORDANT RESULTS IN ABC
|
Harbeck, Nadia
|
|
2015
|
24 |
S3 |
p. S30-S31
2 p.
|
artikel
|
| 19 |
IN34 BREAST CANCER CARE ACCESS AND AFFORDABILITY: ARE DRUGS THE MAIN ISSUE IN EUROPE?
|
Taylor, David
|
|
2015
|
24 |
S3 |
p. S33-
1 p.
|
artikel
|
| 20 |
IN17 CAN IMMUNE-BASED THERAPIES BE THE KEY?
|
Curigliano, Giuseppe
|
|
2015
|
24 |
S3 |
p. S27-
1 p.
|
artikel
|
| 21 |
IN35 CAN WE REALLY APPLY INTERNATIONAL GUIDELINES IN LIMITED RESOURCES COUNTRIES?
|
Bhattacharyya, G.S.
|
|
2015
|
24 |
S3 |
p. S33-S34
2 p.
|
artikel
|
| 22 |
IN23 CIRCULATING TUMOR CELLS AND TUMOR DNA: ARE LIQUID BIOPSIES A DREAM?
|
Pierga, Jean-Yves
|
|
2015
|
24 |
S3 |
p. S29-S30
2 p.
|
artikel
|
| 23 |
IN24 CLONAL EVOLUTION IN BREAST CANCER PATIENTS AND PATIENT DERIVED XENOGRAFTS
|
Aparicio, Sam
|
|
2015
|
24 |
S3 |
p. S30-
1 p.
|
artikel
|
| 24 |
IN28 DURATION OF FIRST-LINE CHEMOTHERAPY IN METASTATIC BREAST CANCER
|
Gennari, Alessandra
|
|
2015
|
24 |
S3 |
p. S31-
1 p.
|
artikel
|
| 25 |
IN22 DYSPNEA: THE HARDEST SYMPTOM TO CONTROL?
|
Aapro, Matti
|
|
2015
|
24 |
S3 |
p. S29-
1 p.
|
artikel
|
| 26 |
IN19 IMAGING RECEPTOR EXPRESSION AND GLYCOLYTIC ACTIVITY USING PET-CT TO INDIVIDUALIZE TREATMENT IN METASTATIC HER2 POSITIVE BREAST CANCER (MBC)
|
Flamen, P.
|
|
2015
|
24 |
S3 |
p. S28-
1 p.
|
artikel
|
| 27 |
IN36 IS A TWO-SPEED (RICH VS POOR) ONCOLOGY INEVITABLE?
|
Sledge, George W.
|
|
2015
|
24 |
S3 |
p. S34-
1 p.
|
artikel
|
| 28 |
IN14 IS OVARIAN ABLATION MANDATORY IN PRE-MENOPAUSAL ER+ ABC PATIENTS?
|
Bergh, Jonas
|
|
2015
|
24 |
S3 |
p. S26-
1 p.
|
artikel
|
| 29 |
IN03 IS THERE AN OPTIMAL TREATMENT SEQUENCE FOR HER2 POSITIVE ADVANCED BREAST CANCER?
|
Arora, Shagun
|
|
2015
|
24 |
S3 |
p. S21-S22
2 p.
|
artikel
|
| 30 |
IN06 LIVING ON BORROWED TIME: LONG TERM RESPONDERS
|
Mertz, Shirley A.
|
|
2015
|
24 |
S3 |
p. S23-
1 p.
|
artikel
|
| 31 |
IN32 LIVING WITH MBC IS LIKE WALKING ON A TIGHT ROPE, A BALANCING ACT USING ALL RESOURCES, TO HOLD ON AND REACH THE OTHER END
|
Papadopoulos, Evi
|
|
2015
|
24 |
S3 |
p. S33-
1 p.
|
artikel
|
| 32 |
IN01 LIVING WITH METASTATIC BONE DISEASE – THE POSITIVE IMPACT OF BONE-TARGETED TREATMENTS
|
Coleman, Robert
|
|
2015
|
24 |
S3 |
p. S21-
1 p.
|
artikel
|
| 33 |
IN05 LONG TERM SURVIVAL WITH ADVANCED DISEASE. CHALLENGES FOR THE PATIENT, THEIR SUPPORT SYSTEM AND CARE GIVERS
|
Gelmon, Karen
|
|
2015
|
24 |
S3 |
p. S23-
1 p.
|
artikel
|
| 34 |
IN02 METAVIVOR: FIGHTING PREJUDICE
|
Corneliussen-James, CJ (Dian)
|
|
2015
|
24 |
S3 |
p. S21-
1 p.
|
artikel
|
| 35 |
IN07 NEW DRUGS, NEW SIDE EFFECTS: ENDOCRINE SIDE EFFECTS
|
Eniu, Alexandra
|
|
2015
|
24 |
S3 |
p. S23-S24
2 p.
|
artikel
|
| 36 |
IN21 OPTIMAL MANAGEMENT OF FATIGUE
|
Roila, Fausto
|
|
2015
|
24 |
S3 |
p. S29-
1 p.
|
artikel
|
| 37 |
IN04 OPTIMAL MANAGEMENT OF HER-2+ ABC
|
Krop, Ian E.
|
|
2015
|
24 |
S3 |
p. S22-S23
2 p.
|
artikel
|
| 38 |
IN15 OPTIMAL MANAGEMENT OF TRIPLE NEGATIVE METASTATIC BREAST CANCER (TODAY)
|
Carey, Lisa A.
|
|
2015
|
24 |
S3 |
p. S26-S27
2 p.
|
artikel
|
| 39 |
IN25 PATIENT XENOGRAFT MODELS: CAN AN “AVATAR” HELP?
|
Hoffmann, Jens
|
|
2015
|
24 |
S3 |
p. S30-
1 p.
|
artikel
|
| 40 |
IN16 RESURRECTING PARP INHIBITION
|
Tutt, Andrew
|
|
2015
|
24 |
S3 |
p. S27-
1 p.
|
artikel
|
| 41 |
IN13 REVOLUTIONIZING ER+ ABC MANAGEMENT: ESR1 AND OTHER SUSPECTS IN RESISTANCE
|
Diéras, Véronique
|
|
2015
|
24 |
S3 |
p. S25-S26
2 p.
|
artikel
|
| 42 |
IN29 SURGERY OF THE PRIMARY TUMOUR: SHOULD THE RECOMMENDATION BE CHANGED?
|
Cardoso, Maria-João
|
|
2015
|
24 |
S3 |
p. S31-S32
2 p.
|
artikel
|
| 43 |
IN30 SURVIVORSHIP IN ABC: WHICH ARE THE MAIN ISSUES?
|
Pagani, Olivia
|
|
2015
|
24 |
S3 |
p. S32-
1 p.
|
artikel
|
| 44 |
IN33 THE COST OF BREAST CANCER: A GLOBAL PERSPECTIVE
|
Sullivan, Richard
|
|
2015
|
24 |
S3 |
p. S33-
1 p.
|
artikel
|
| 45 |
IN12 THE ROLE OF CDK AND PI3K/MTOR INHIBITORS
|
André, Fabrice
|
|
2015
|
24 |
S3 |
p. S25-
1 p.
|
artikel
|
| 46 |
IN10 THE ROLE OF PATIENT REPORTED OUTCOMES
|
Fallowfield, Lesley
|
|
2015
|
24 |
S3 |
p. S25-
1 p.
|
artikel
|
| 47 |
IN20 TOWARDS IMPROVED DISEASE OUTCOME COMBINED WITH A REDUCTION OF TOXICITY USING NEW RADIATION THERAPY TECHNIQUES
|
Meijer, Hanneke J.M.
|
|
2015
|
24 |
S3 |
p. S28-
1 p.
|
artikel
|
| 48 |
IN09 TOXICITY OF MODERN IMMUNOTHERAPY APPROACHES
|
Barrios, Carlos H.
|
|
2015
|
24 |
S3 |
p. S24-S25
2 p.
|
artikel
|
| 49 |
IN08 TREATMENT ASSOCIATED RISKS: IDENTIFYING AND TREATING PULMONARY TOXICITY
|
Rugo, Hope S.
|
|
2015
|
24 |
S3 |
p. S24-
1 p.
|
artikel
|
| 50 |
IN18 TRIPLE NEGATIVE BREAST CANCER: THE ROLE OF ANDROGEN RECEPTOR AND ITS INHIBITORS
|
Hudis, Clifford A.
|
|
2015
|
24 |
S3 |
p. S27-S28
2 p.
|
artikel
|
| 51 |
OR128 CTL AND IGG RESPONSE TO TUMOR-ASSOCIATED ANTIGENS AS PREDICTIVE FACTORS OF THERAPEUTIC PEPTIDE VACCINATION FOR PATIENTS WITH METASTATIC RECURRENT BREAST CANCER
|
Toh, Uhi
|
|
2015
|
24 |
S3 |
p. S65-S66
2 p.
|
artikel
|
| 52 |
OR51 NO IMPACT OF INCREASING SYMPTOMS ON QUALITY OF LIFE? LONGITUDINAL DATA FROM THE GERMAN MALIFE-PROJECT ON PATIENTS RECEIVING MONOCHEMO- AND ENDOCRINE TREATMENT FOR ADVANCED BREAST CANCER – RESULTS FROM THE TMK REGISTRY GROUP
|
Marschner, Norbert
|
|
2015
|
24 |
S3 |
p. S39-
1 p.
|
artikel
|
| 53 |
OR37 UNMET PSYCHOSOCIAL AND QUALITY OF LIFE NEEDS OF PATIENTS LIVING WITH METASTATIC BREAST CANCER
|
Hurlbert, Marc
|
|
2015
|
24 |
S3 |
p. S34-
1 p.
|
artikel
|
| 54 |
P096 CHARACTERISATION OF BREAST CANCER BRAIN METASTASES THROUGH A 21-YEAR PERIOD – A STUDY FROM THE SWEDISH ASSOCIATION OF BREAST ONCOLOGISTS (SABO)
|
Thulin, Anna
|
|
2015
|
24 |
S3 |
p. S54-S55
2 p.
|
artikel
|
| 55 |
P077 LOCALLY ADVANCED BREAST CANCER IN YOUNG FEMALE. THE EGYPTIAN NATIONAL CANCER INSTITUTE EXPERIENCE
|
Helal, Amany
|
|
2015
|
24 |
S3 |
p. S48-
1 p.
|
artikel
|
| 56 |
PO134 ANALYSIS OF PRIMARY BREAST CANCER (BC) EXPRESSION OF PROGRAMMED CELL DEATH 1 (PD-1) RECEPTOR AND PROGRAMMED DEATH LIGAND 1 (PD-L1) TO DETERMINE ASSOCIATIONS WITH CLINICAL CHARACTERISTICS AND OUTCOMES
|
Vidula, Neelima
|
|
2015
|
24 |
S3 |
p. S67-S68
2 p.
|
artikel
|
| 57 |
PO132 APOPTOTIC ACTIVITIES OF RECOMBINANT CELL SURFACE RECEPTOR FAS WITHIN TUMOR MICROENVIRONMENT OF BREAST CARCINOMA
|
Abou-Shousha, Seham Abdel-Moneim
|
|
2015
|
24 |
S3 |
p. S67-
1 p.
|
artikel
|
| 58 |
PO54 A RETROSPECTIVE MULTICENTER OBSERVATION STUDY IN METASTATIC BREAST CANCER PATIENTS: COMPARATIVE ANALYSIS ON EFFICACY OF ERIBULIN MESYLATE WITH TAXANE REGIMENS (INCLUDING COMBINATION WITH BEVACIZUMAB)
|
Kikuchi, Yasuko
|
|
2015
|
24 |
S3 |
p. S40-
1 p.
|
artikel
|
| 59 |
PO135 AT A GLANCE THE BRCAS EPIGENETIC STUDY IN PADANG, WEST SUMATERA, INDONESIA
|
Harahap, Wirsma Arif
|
|
2015
|
24 |
S3 |
p. S68-
1 p.
|
artikel
|
| 60 |
PO56 BOLERO-4: A PHASE 2, OPEN-LABEL, MULTICENTER, SINGLE-ARM TRIAL INVESTIGATING THE EFFICACY AND SAFETY OF FIRST-LINE EVEROLIMUS (EVE) IN COMBINATION WITH LETROZOLE (LET) IN POSTMENOPAUSAL PATIENTS (PTS) WITH ESTROGEN RECEPTOR–POSITIVE (ER+), HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2–NEGATIVE (HER2–) METASTATIC OR LOCALLY ADVANCED UNRESECTABLE BREAST CANCER (BC)
|
Bachelot, Thomas
|
|
2015
|
24 |
S3 |
p. S41-
1 p.
|
artikel
|
| 61 |
PO69 BRACHIAL PLEXOPATHY IN METASTATIC BREAST CANCER: A REVIEW OF PATIENT CHARACTERISTICS AND DIAGNOSIS IN AN IRISH TERTIARY REFERRAL CENTRE
|
O'Leary, Connor
|
|
2015
|
24 |
S3 |
p. S45-S46
2 p.
|
artikel
|
| 62 |
PO97 BRAIN METASTASES IN HER2- POSITIVE BREAST CANCER PATIENTS: A SINGLE INSTITUTE EXPERIENCE
|
Mehmood, Tahir
|
|
2015
|
24 |
S3 |
p. S55-
1 p.
|
artikel
|
| 63 |
PO117 CAN WE MAKE A PORTRAIT OF WOMEN WITH INOPERABLE LOCALLY ADVANCED BREAST CANCER? THE EXPERIENCE OF THE BREAST UNIT OF SOUTHERN SWITZERLAND (CSSI)
|
Montagna, Giacomo
|
|
2015
|
24 |
S3 |
p. S62-
1 p.
|
artikel
|
| 64 |
PO140 CHANGING IN TUMOR BIOLOGY OF TRIPLE NEGATIVE BREAST CANCER BETWEEN PRIMARY AND METASTATIC LESIONS
|
Milovic-Kovacevic, Marijana
|
|
2015
|
24 |
S3 |
p. S70-
1 p.
|
artikel
|
| 65 |
PO57 CLINICAL EFFICACY OF LH-RH ANALOGUE PLUS AROMATASE INHIBITOR IN PREMENOPAUSAL WOMEN WITH ESTROGEN RECEPTOR–POSITIVE ADVANCED BREAST CANCER: A SINGLE-INSTITUTION RETROSPECTIVE STUDY
|
Utsumi, Toshiaki
|
|
2015
|
24 |
S3 |
p. S41-
1 p.
|
artikel
|
| 66 |
PO53 CLINICAL IMPACT OF METRONOMIC ORAL COMBINATION CHEMOTHERAPY WITH CAPECITABINE AND CYCLOPHOSPHAMIDE IN PATIENTS WITH METASTATIC BREAST CANCER
|
Fujihara, Miwa
|
|
2015
|
24 |
S3 |
p. S40-
1 p.
|
artikel
|
| 67 |
PO130 CLINICAL UTILITY OF THE EXPRESSION OF HER3, HER4, PTEN AND IGF1R IN HER2-POSITIVE ADVANCED OR METASTATIC BREAST CANCER
|
Ito, Hiroki
|
|
2015
|
24 |
S3 |
p. S66-
1 p.
|
artikel
|
| 68 |
PO81 COMPLIANCE AND PERSISTENCE TO PALLIATIVE ENDOCRINE THERAPY IN METASTATIC BREAST CANCER
|
Güth, Uwe
|
|
2015
|
24 |
S3 |
p. S49-S50
2 p.
|
artikel
|
| 69 |
PO63 CURE IN METASTATIC BREAST CANCER: AN AGGRESSIVE APPROACH DOES NOT APPEAR TO BE THE KEY TO THE BLACK BOX
|
Güth, Uwe
|
|
2015
|
24 |
S3 |
p. S43-S44
2 p.
|
artikel
|
| 70 |
PO83 CURRENT STATUS OF THE MANAGEMENT OF ADVANCED RH+/HER2-BREAST CANCER IN MOROCCO
|
Hassan, Errihani
|
|
2015
|
24 |
S3 |
p. S50-
1 p.
|
artikel
|
| 71 |
PO133 DIFFERENTIAL EXPRESSION OF PLASMA MEMBRANE PROTEINS IN INFLAMMATORY BREAST CANCER VIA STABLE ISOTOPE LABELED AMINO ACIDS IN CULTURE (SILAC)
|
Martinez-Montemayor, Michelle M.
|
|
2015
|
24 |
S3 |
p. S67-
1 p.
|
artikel
|
| 72 |
PO58 DOES PREVIOUS NEOADJUVANT/ADJUVANT TRASTUZUMAB INFLUENCE THE DISEASE OUTCOME OF METASTATIC HER2 POSITIVE BREAST CANCER PATIENTS TREATED WITH FIRST LINE TRASTUZUMAB AND CHEMOTHERAPY
|
Milosevic, Snezana
|
|
2015
|
24 |
S3 |
p. S41-S42
2 p.
|
artikel
|
| 73 |
PO59 DURABLE REMISSIONS WITH TRASTUZUMAB TREATMENT FOR HER2 POSITIVE METASTATIC BREAST CANCER – SINGLE CENTER EXPERIENCE
|
Tomasevic, Zoran
|
|
2015
|
24 |
S3 |
p. S42-
1 p.
|
artikel
|
| 74 |
PO39 EFFECTIVE ADVOCACY FOR WOMEN WITH METASTATIC BREAST CANCER: A EUROPEAN PERSPECTIVE
|
Knox, Susan
|
|
2015
|
24 |
S3 |
p. S35-
1 p.
|
artikel
|
| 75 |
PO55 EFFICACY AND SAFETY OF ERIBULIN IN ANTHRACYCLINE AND TAXANE-PRETREATED PATIENTS: RUSSIAN EXPERIENCE
|
Kovalenko, Elena
|
|
2015
|
24 |
S3 |
p. S40-
1 p.
|
artikel
|
| 76 |
PO112EFFICACY OF NEPA, THE FIRST COMBINATION ANTIEMETIC AGENT, IN PATIENTS WITH BREAST CANCER RECEIVING ANTHRACYCLINE/CYCLOPHOSPHAMIDE (AC) OR NON-AC CHEMOTHERAPY
|
Rugo, Hope
|
|
2015
|
24 |
S3 |
p. S60-
1 p.
|
artikel
|
| 77 |
PO79 ELDERLY METASTATIC BREAST CANCER AT DIAGNOSIS: A SINGLE INSTITUTION EXPERIENCE
|
Carvalho, Amanda Nobre
|
|
2015
|
24 |
S3 |
p. S49-
1 p.
|
artikel
|
| 78 |
PO78 ELDERLY WOMEN AND BREAST CANCER: CHARACTERIZATION OF TREATMENT PRACTICES
|
Freitas, Diana
|
|
2015
|
24 |
S3 |
p. S48-S49
2 p.
|
artikel
|
| 79 |
PO80 ELEVATED NEUTROPHIL TO LYMPHOCYTE RATIO PREDICTS WORSE SURVIVAL OUTCOME AFTER RECURRENCE FOR PATIENTS WITH TRIPLE NEGATIVE BREAST CANCER
|
Iwase, Toshiaki
|
|
2015
|
24 |
S3 |
p. S49-
1 p.
|
artikel
|
| 80 |
PO82 EPIDEMIOLOGY AND THERAPEUTIC MANAGEMENT OF METASTATIC BREAST CANCER IN BULGARIA: A RETROSPECTIVE COHORT STUDY
|
Timcheva, Konstanta
|
|
2015
|
24 |
S3 |
p. S50-
1 p.
|
artikel
|
| 81 |
PO70 ESTROGEN RECEPTOR AS A NEGATIVE PREDICTOR OF COMPLETE PATHOLOGICAL RESPONSE IN HER2 POSITIVE LOCALLY ADVANCED BREAST CANCER
|
Canario, Rita
|
|
2015
|
24 |
S3 |
p. S46-
1 p.
|
artikel
|
| 82 |
PO142 EVOLUTION OF THE EXPRESSION OF CIRCULATING TUMOR CELLS (CTC) AND CK-19 MRNA (CK19) AS PROGNOSTIC FACTORS IN HEAVILY PRETREATED METASTATIC BREAST CANCER
|
Murillo, Serafín Morales
|
|
2015
|
24 |
S3 |
p. S70-S71
2 p.
|
artikel
|
| 83 |
PO43 “FIGHT, LIVE, KEEP SMILING”: THE FIRST ITALIAN BLOG ABOUT METASTATIC BREAST CANCER (MBC) ADDRESSED TO THE GENERAL PUBLIC. A QUALI-QUANTITATIVE ANALYSIS OF ALL THE COMMENTS POSTED ONLINE ON THE BLOG OF THE EUROPA DONNA ITALIA MBC WORKING GROUP
|
Balena, Francesca
|
|
2015
|
24 |
S3 |
p. S36-S37
2 p.
|
artikel
|
| 84 |
PO62 FIRST LINE TRASTUZUMAB-BASED THERAPY IN HER2-POSITIVE METASTATIC BREAST CANCER PATIENTS PRESENTING WITH DE NOVO OR RECURRENT DISEASE: A MULTICENTER RETROSPECTIVE COHORT STUDY
|
Lambertini, Matteo
|
|
2015
|
24 |
S3 |
p. S43-
1 p.
|
artikel
|
| 85 |
PO131 HETEROGENEITY IN THE EXPRESSION OF HORMONE RECEPTORS AND HER2 BETWEEN THE PRIMARY BREAST CANCER AND PULMONARY METASTASIS
|
Sato, Masako
|
|
2015
|
24 |
S3 |
p. S66-S67
2 p.
|
artikel
|
| 86 |
PO46 I AM ANNA: EXPLORING METASTATIC BREAST CANCER THROUGH THE EYES OF A YOUNG WOMAN
|
Ginsberg, Shawna
|
|
2015
|
24 |
S3 |
p. S37-
1 p.
|
artikel
|
| 87 |
PO145 ICORG 13-01 ABC SURVEY: ARE WE MEETING THE NEEDS OF PATIENTS WITH ADVANCED BREAST CANCER (ABC) IN IRELAND? A NATIONWIDE SURVEY
|
Battley, Jodie E.
|
|
2015
|
24 |
S3 |
p. S71-S72
2 p.
|
artikel
|
| 88 |
PO47 IDENTIFYING DEFICITS AND NEEDS FROM STAKEHOLDERS ABOUT PALLIATIVE CARE ISSUES
|
Pramod, Shankpal
|
|
2015
|
24 |
S3 |
p. S37-S38
2 p.
|
artikel
|
| 89 |
PO100 IMRT-SIB FOR LOCALLY ADVANCED INOPERABLE BREAST CANCER PATIENTS
|
Gabrys, Dorota
|
|
2015
|
24 |
S3 |
p. S56-
1 p.
|
artikel
|
| 90 |
PO45 INFORMATION NEEDS OF YOUNG WOMEN WITH METASTATIC BREAST CANCER TO MANAGE THEIR TREATMENT, SIDE EFFECTS AND CLINICAL TRIALS
|
Sutliff, Medha
|
|
2015
|
24 |
S3 |
p. S37-
1 p.
|
artikel
|
| 91 |
PO44 IN OUR SHOES: RAISING THE VOICES OF MBC PATIENTS
|
Marx-Rubiner, Lori
|
|
2015
|
24 |
S3 |
p. S37-
1 p.
|
artikel
|
| 92 |
PO98 IS BRAIN METASTASES LOCATION ASSOCIATED WITH PROGNOSIS IN BREAST CANCER PATIENTS?
|
Widera, Karolina
|
|
2015
|
24 |
S3 |
p. S55-
1 p.
|
artikel
|
| 93 |
PO42 MAKE YOUR DIALOGUE COUNT SURVEY: ADDRESSING COMMUNICATION GAPS BETWEEN PATIENTS WITH ADVANCED BREAST CANCER, THEIR CAREGIVERS AND ONCOLOGISTS AND UNDERSTANDING INFORMATION AND EMOTIONAL NEEDS TO IMPROVE TREATMENT AND SIDE EFFECT MANAGEMENT
|
Coons, Helen L.
|
|
2015
|
24 |
S3 |
p. S36-
1 p.
|
artikel
|
| 94 |
PO110 METASTASES OF LOBULAR BREAST CARCINOMA IN THE TERMINAL ILEUM AND ILEOCAECAL VALVE
|
Abdalla, Sala
|
|
2015
|
24 |
S3 |
p. S59-
1 p.
|
artikel
|
| 95 |
PO64 METRONOMIC CHEMOTHERAPY (CHT) COMBINATION OF VINORELBINE (VRL) AND CAPECITABINE (CAPE) IN HER2- ADVANCED BREAST CANCER (ABC) PATIENTS (PTS) DOES NOT IMPAIR GLOBAL QOL. FIRST RESULTS OF THE VICTOR-2 STUDY
|
Elena Cazzaniga, Marina
|
|
2015
|
24 |
S3 |
p. S44-
1 p.
|
artikel
|
| 96 |
PO41 MIDDLE EASTERN ABC/MBC PATIENTS:OVERCOMING THE TRIPLE-BURDEN OF STIGMATIZATION, LACK OF INFORMATION AND RECURRENT ILLNESS
|
Azmi, Rania
|
|
2015
|
24 |
S3 |
p. S36-
1 p.
|
artikel
|
| 97 |
PO71 MONITORING THERAPY RESPONSE IN METASTATIC BREAST CANCER USING TUMOUR MARKERS CA15-3 AND TPS
|
Sundquist, Marie
|
|
2015
|
24 |
S3 |
p. S46-
1 p.
|
artikel
|
| 98 |
PO66 NEOADJUVANT CHEMOTHERAPY FOR LOCALLY ADVANCED BREAST CANCER; A SOLUTION TO AVOID MASTECTOMY
|
Tarek Awad, Ahmed
|
|
2015
|
24 |
S3 |
p. S44-S45
2 p.
|
artikel
|
| 99 |
PO67 NEO-ADJUVANT HORMONAL THERAPY FOR LOCALLY ADVANCED BREAST CANCER
|
Katselashvili, Lika
|
|
2015
|
24 |
S3 |
p. S45-
1 p.
|
artikel
|
| 100 |
PO106 N2 LYMPH NODES POST-PRIMARY CHEMOTHERAPY MAY PREDICT RECURRENCE IN LOCALLY ADVANCED BREAST CANCER
|
Ann Benn, Carol
|
|
2015
|
24 |
S3 |
p. S58-
1 p.
|
artikel
|
| 101 |
PO108 NOVEL AND SAFE TECHNIQUES IN IMMEDIATE BREAST RECONSTRUCTION FOR LOCALLY ADVANCED BREAST CANCER, PARTICULARLY INFLAMMATORY BREAST CANCER
|
Venter, Marisse
|
|
2015
|
24 |
S3 |
p. S59-
1 p.
|
artikel
|
| 102 |
PO61 ORAL VINORELBINE IN COMBINATION WITH TRASTUZUMAB AS A FIRST LINE THERAPY OF METASTATIC OR LOCALLY ADVANCED HER2-POSITIVE BREAST CANCER
|
Farhat, Fadi
|
|
2015
|
24 |
S3 |
p. S42-S43
2 p.
|
artikel
|
| 103 |
PO73 OUTPATIENT CATUMAXOMAB THERAPY IN METASTATIC BREAST CANCER PATIENTS SUFFERING FROM MALIGNANT EFFUSIONS DUE TO PERITONEAL OR PLEURAL CARCINOMATOSIS: A SINGLE INSTITUTION EXPERIENCE
|
Martin Kurbacher, Christian
|
|
2015
|
24 |
S3 |
p. S47-
1 p.
|
artikel
|
| 104 |
PO138 P-CADHERIN: A CANDIDATE BIOMARKER FOR AXILLARY-BASED BREAST CANCER DECISIONS IN CLINICAL PRACTICE
|
Dionisio, Maria Rita
|
|
2015
|
24 |
S3 |
p. S69-
1 p.
|
artikel
|
| 105 |
PO65 PHASE II TRIAL OF METRONOMIC COMBINATION CHEMOTHERAPY WITH ORAL REGIMEN IN HEAVILY PRETREATED METASTATIC BREAST CANCER
|
Rammohan, Prasanna
|
|
2015
|
24 |
S3 |
p. S44-
1 p.
|
artikel
|
| 106 |
PO101 PROGNOSTIC FACTORS AFTER GAMMA KNIFE RADIOSURGERY IN BREAST CANCER PATIENTS WITH BRAIN METASTASES
|
Hayama, Shoko
|
|
2015
|
24 |
S3 |
p. S56-
1 p.
|
artikel
|
| 107 |
PO143 PROGNOSTIC IMPACT OF CIRCULATING TUMOR CELL CLUSTERS AND APOPTOSIS IN METASTATIC BREAST CANCER
|
Jansson, Sara
|
|
2015
|
24 |
S3 |
p. S71-
1 p.
|
artikel
|
| 108 |
PO139 RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B (RANK) EXPRESSION IN PRIMARY BREAST CANCER CORRELATES WITH RECURRENCE FREE SURVIVAL AND DEVELOPMENT OF BONE METASTASES IN THE I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657)
|
Vidula, Neelima
|
|
2015
|
24 |
S3 |
p. S69-S70
2 p.
|
artikel
|
| 109 |
PO122 SODIUM FLUORIDE PET/CT: A SUPERIOR IMAGING MODALITY IN EVALUATION OF OSSEOUS METASTATIC DISEASE
|
Harrold, Emily
|
|
2015
|
24 |
S3 |
p. S63-S64
2 p.
|
artikel
|
| 110 |
Poster Session
|
|
|
2015
|
24 |
S3 |
p. S18-S19
2 p.
|
artikel
|
| 111 |
PO105 SUCCESS AND FAILURE OF PRIMARY MEDICAL, NON-OPERATIVE MANAGEMENT IN PATIENTS WHO PRESENT WITH STAGE IV BREAST CANCER
|
Güth, Uwe
|
|
2015
|
24 |
S3 |
p. S58-
1 p.
|
artikel
|
| 112 |
PO141 SUCCESSFUL USE OF HER2 TARGETED AGENTS IN PATIENTS WITH HEAVILY PRETREATED HER2-NEGATIVE METASTATIC BREAST CANCER PRESENTING WITH ELEVATED SERUM LEVELS OF THE HER2 EXTRACELLULAR DOMAIN AND/OR HER2 OVEREXPRESSING CIRCULATING TUMOR CELLS
|
Kurbacher, Christian Martin
|
|
2015
|
24 |
S3 |
p. S70-
1 p.
|
artikel
|
| 113 |
PO107 SURGICAL RESECTION OF THE PRIMARY TUMOR IS ASSOCIATED WITH INCREASED LONG-TERM SURVIVAL IN PATIENTS WITH STAGE IV BREAST CANCER
|
Sukhotko, Anna
|
|
2015
|
24 |
S3 |
p. S58-S59
2 p.
|
artikel
|
| 114 |
PO144 SYNERGISTIC ANTITUMOR EFFECTS OF CROCIN COMBINED WITH HYPERTHERMIA ON BREAST CANCER CELLS
|
Hoshyar, Reyhane
|
|
2015
|
24 |
S3 |
p. S71-
1 p.
|
artikel
|
| 115 |
PO48 TERMINOLOGY USED IN ADVANCED BREAST CANCER AND THE NEED FOR CONSISTENCY
|
Leadbeater, Maria
|
|
2015
|
24 |
S3 |
p. S38-
1 p.
|
artikel
|
| 116 |
PO75 THE CTPET/MDST RATIO: AN INTRODUCTION OF A QUANTITATIVE MEASURE OF EFFECTIVE PALLIATIVE ENDOCRINE THERAPY IN METASTATIC BREAST CANCER
|
Güth, Uwe
|
|
2015
|
24 |
S3 |
p. S47-S48
2 p.
|
artikel
|
| 117 |
PO115 THE EMOTIONAL TOLL OF METASTATIC BREAST CANCER ON YOUNG WOMEN
|
Sutliff, Medha
|
|
2015
|
24 |
S3 |
p. S61-
1 p.
|
artikel
|
| 118 |
PO109 THE IMPACT OF LOCOREGIONAL TREATMENT OF PRIMARY METASTATIC BREAST CANCER
|
Liubota, Roman
|
|
2015
|
24 |
S3 |
p. S59-
1 p.
|
artikel
|
| 119 |
PO116 THE LAST QUARTER OF A HONEYMOON – A WEDDING'S STORY
|
Pereira, Jose
|
|
2015
|
24 |
S3 |
p. S61-S62
2 p.
|
artikel
|
| 120 |
PO72 THERAPEUTIC EFFECT PREDICTION BASED ON BIOMARKERS IN THE PLEURAL EFFUSION SPECIMENS OF BREAST CANCER PATIENTS
|
Nakamura, Rikiya
|
|
2015
|
24 |
S3 |
p. S46-S47
2 p.
|
artikel
|
| 121 |
PO76 THERAPEUTIC STRATEGY FOR RECURRENT HER2-POSITIVE BREAST CANCER PATIENTS
|
Nishimura, Akimasa
|
|
2015
|
24 |
S3 |
p. S48-
1 p.
|
artikel
|
| 122 |
PO60 THE ROLE OF LAPATINIB IN THE MANAGEMENT OF HER2-POSITIVE METASTATIC BREAST CANCER: A REVIEW OF A SINGLE INSTITUTION'S EXPERIENCE DURING THE TRASTUZUMAB AND LAPATINIB ERA
|
Watanabe, Junichiro
|
|
2015
|
24 |
S3 |
p. S42-
1 p.
|
artikel
|
| 123 |
PO104 THE SURGICAL MANAGEMENT OF LUNG NODULES IN BREAST CANCER PATIENTS
|
Matsuura, Kazuo
|
|
2015
|
24 |
S3 |
p. S57-S58
2 p.
|
artikel
|
| 124 |
PO99 TREATMENT OUTCOMES OF BREAST CANCER BRAIN METASTASES
|
Ratosa, Ivica
|
|
2015
|
24 |
S3 |
p. S55-S56
2 p.
|
artikel
|
| 125 |
PO68 TRIPLE NEGATIVE BREAST CANCER – NEOADJUVANT CHEMOTHERAPY RESPONSE EVALUATION WITH TAXANE/ANTHRACYCLINE PROTOCOL – SINGLE CENTRE 5 YEARS EXPERIENCE
|
de Paulo, Judy Vicente
|
|
2015
|
24 |
S3 |
p. S45-
1 p.
|
artikel
|
| 126 |
PO40 UNMET NEEDS OF AUSTRALIAN WOMEN WITH METASTATIC BREAST CANCER WITH FINANCIALLY DEPENDENT CHILDREN: THE CONSUMER PERSPECTIVE
|
Spence, Danielle
|
|
2015
|
24 |
S3 |
p. S35-
1 p.
|
artikel
|
| 127 |
PO114 USING OF HEPATOPROTECTORS IN THE DRUG TREATMENT OF PATIENTS WITH ADVANCED BREAST CANCER
|
Ibragimov, Jamshid
|
|
2015
|
24 |
S3 |
p. S61-
1 p.
|
artikel
|
| 128 |
PO74 WHICH IS MORE BENEFICIAL AS AN INITIAL THERAPY FOR THE FIRST DISTANT METASTASIS OF BREAST CANCER: CHEMOTHERAPY OR ENDOCRINE THERAPY FOR HORMONE RECEPTOR-POSITIVE, HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2-NEGATIVE BREAST CANCER PATIENTS? A SINGLE-CENTER STUDY
|
Yamamura, Jun
|
|
2015
|
24 |
S3 |
p. S47-
1 p.
|
artikel
|
| 129 |
PR126 ACCESS TO CARE FOR ADVANCED BREAST CANCER IN MIDDLE-INCOME COUNTRY: EXAMPLE OF MOROCCO
|
Berrada, Narjiss
|
|
2015
|
24 |
S3 |
p. S65-
1 p.
|
artikel
|
| 130 |
PR148 ANDROGEN RECEPTOR (AR) EXPRESSION AS A PROMISING INDEX OF THE PREDICTION OF DISTANT METASTASIS OF TRIPLE NEGATIVE BREAST CANCER (TNBC)
|
Miwa, Noriko
|
|
2015
|
24 |
S3 |
p. S73-
1 p.
|
artikel
|
| 131 |
PR90 BASIC CLINICAL ISSUES OF INFLAMMATORY CARCINOMA OF THE BREAST
|
Bebeci-Docaj, Arjeta
|
|
2015
|
24 |
S3 |
p. S52-S53
2 p.
|
artikel
|
| 132 |
PR127 CHANGES OF STATISTICS OF BREAST CANCER IN UKRAINE DURING THE PERIOD OF 2003-2013
|
Zrelykh, Liliya
|
|
2015
|
24 |
S3 |
p. S65-
1 p.
|
artikel
|
| 133 |
PR87 COMBINATION THERAPY PERUZUMAB, TRASTUZUMAB AND DOCETAXEL FOR ADVANCED OR RECURRENT BREAST CANCER PATIENTS IN THE LATE LINE
|
Morimoto, Takashi
|
|
2015
|
24 |
S3 |
p. S51-
1 p.
|
artikel
|
| 134 |
PR113 COMPARATIVE ASSESSMENT OF ANALGESIC THERAPY IN PATIENTS WITH BREAST CANCER IN THE TERMINAL STAGE
|
Kadirova, Zulaykho
|
|
2015
|
24 |
S3 |
p. S60-S61
2 p.
|
artikel
|
| 135 |
PR118 COMPARISON OF INTEGRATIVE CARE EXPECTATIONS BETWEEN BREAST CANCER PATIENTS AND BREAST ONCOLOGY PHYSICIANS IN AN ETHNICALLY DIVERSE POPULATION
|
Hansra, Damien
|
|
2015
|
24 |
S3 |
p. S62-
1 p.
|
artikel
|
| 136 |
PR137 CONTRADICTORIES IN VITAMIN D SUPPLEMENTATION ON GENE EXPRESSION OF MICRORNAS INVOLVING IN BREAST CARCINOGENESIS
|
Koujan, Soraiya Ebrahimpour
|
|
2015
|
24 |
S3 |
p. S69-
1 p.
|
artikel
|
| 137 |
PR120 DIFFICULTIES IN PROVIDING PALLIATIVE CARE IN RURAL INDIA (WEST BENGAL) – EXPERIENCE OF AN NGO
|
Manna, Aditya
|
|
2015
|
24 |
S3 |
p. S63-
1 p.
|
artikel
|
| 138 |
PR151 EFFECTS OF PHYTOESTROGEN EXTRACTS ISOLATED FROM ELDER FLOWER ON HORMONE PRODUCTION AND RECEPTOR EXPRESSION OF TROPHOBLAST TUMOUR CELLS JEG-3 AND BEWO, AS WELL AS MCF-7 BREAST CANCER CELLS
|
Schröder, Lennard
|
|
2015
|
24 |
S3 |
p. S74-
1 p.
|
artikel
|
| 139 |
PR154 EVALUATION OF CARDIOTOXICITY IN BREAST CANCER PATIENTS WITH HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR-2 OVEREXPRESSION UNDERGOING TRASUZUMAB TREATMENT
|
Zenovia Antone, Nicoleta
|
|
2015
|
24 |
S3 |
p. S74-S75
2 p.
|
artikel
|
| 140 |
PR88 EXPERIENCE WITH ERIBULIN IN THE TREATMENT OF METASTATIC BREAST CANCER IN TATARSTAN REPUBLIC CLINICAL ONCOLOGICAL DISPENSARY
|
Khasanova, Alfyia
|
|
2015
|
24 |
S3 |
p. S52-
1 p.
|
artikel
|
| 141 |
PR84 FULVESTRANT COMBINED WITH CAPECITABINE MAY BE EFFECTIVE AND WELL TOLERATED FOR PATIENTS WITH ESTROGEN RECEPTOR-POSITIVE, HER2-NEGATIVE METASTATIC BREAST CANCER
|
Nakai, Maki
|
|
2015
|
24 |
S3 |
p. S50-S51
2 p.
|
artikel
|
| 142 |
PR49 GETTING BACK INTO LIFE
|
Mueseler, Shirley Bianca
|
|
2015
|
24 |
S3 |
p. S38-
1 p.
|
artikel
|
| 143 |
PR89 INFLAMMATORY BREAST CANCER – DOES DERMAL LYMPHATIC INVASION INFLUENCE THE OUTCOME?
|
Kolarevic, Daniela
|
|
2015
|
24 |
S3 |
p. S52-
1 p.
|
artikel
|
| 144 |
PR147 INTRATUMORAL MORPHOLOGICAL HETEROGENEITY OF BREAST CANCER AND ITS IMPLICATION IN CHEMOTHERAPY RESISTANCE
|
Gerashchenko, Tatiana
|
|
2015
|
24 |
S3 |
p. S72-
1 p.
|
artikel
|
| 145 |
PR152 IS NGS STILL EFFICIENT IN FINDING NEW GENES FOR BREAST CANCER?
|
Kashyap, Aniruddh
|
|
2015
|
24 |
S3 |
p. S74-
1 p.
|
artikel
|
| 146 |
PR146 LOCOREGIONAL RECURRENCE BY TUMOR BIOLOGY IN BREAST CANCER PATIENTS AFTER PREOPERATIVE CHEMOTHERAPY AND BREAST CONSERVATION TREATMENT
|
Jwa, Eunjin
|
|
2015
|
24 |
S3 |
p. S72-
1 p.
|
artikel
|
| 147 |
PR92 NATIONAL CLINICAL BREAST CANCER REGISTRY: VIEWS AND APPROACHES
|
Pramod, S.
|
|
2015
|
24 |
S3 |
p. S53-
1 p.
|
artikel
|
| 148 |
PR91 NO PALLIATIVE SYSTEMIC ANTINEOPLASTIC THERAPY IN PATIENTS WITH DISTANT METASTATIC BREAST CANCER: A BLIND SPOT IN THE PERCEPTION OF ONCOLOGY?
|
Güth, Uwe
|
|
2015
|
24 |
S3 |
p. S53-
1 p.
|
artikel
|
| 149 |
Programme
|
|
|
2015
|
24 |
S3 |
p. S9-S13
5 p.
|
artikel
|
| 150 |
PR85 OUR TREATMENT STRATEGY FOR PATIENTS WITH HORMONE-RECEPTOR-POSITIVE, HER2-POSITIVE METASTATIC BREAST CANCER
|
Tanaka, Haruo
|
|
2015
|
24 |
S3 |
p. S51-
1 p.
|
artikel
|
| 151 |
PR95 PARANEOPLASTIC CEREBELLAR DEGENERATION AND BREAST CANCER
|
Freitas, Diana
|
|
2015
|
24 |
S3 |
p. S54-
1 p.
|
artikel
|
| 152 |
PR123 PATIENTS’ OWN DECISION ABOUT BECOMING AWARE OF RECURRENCE EARLIER
|
Ishige, Hiroyuki
|
|
2015
|
24 |
S3 |
p. S64-
1 p.
|
artikel
|
| 153 |
PR136 PREDICTIVE VALUE OF MRNA EXPRESSION OF TUBβIII GENE IN THE TREATMENT OF LOCALLY ADVANCED BREAST CANCER
|
Semiglazova, Tatiana
|
|
2015
|
24 |
S3 |
p. S68-
1 p.
|
artikel
|
| 154 |
PR150 PROGNOSTIC IMPACT OF 25-HYDROXYVITAMIN D LEVELS IN EGYPTIAN PATIENTS WITH BREAST CANCER
|
El Shorbagy, Shereen
|
|
2015
|
24 |
S3 |
p. S73-S74
2 p.
|
artikel
|
| 155 |
PR149 PROGNOSTIC SIGNIFICANCE OF KI67 PROTEIN EXPRESSION IN METASTATIC BREAST CANCER SURVIVAL
|
Todorovic-Rakovic, Natasa
|
|
2015
|
24 |
S3 |
p. S73-
1 p.
|
artikel
|
| 156 |
PR50 PSYCHOLOGICAL SUPPORT TO CANCER PATIENT THROUGH VOLUNTEERS AND SURVIVORS
|
Manna, Aditya
|
|
2015
|
24 |
S3 |
p. S38-S39
2 p.
|
artikel
|
| 157 |
PR86 RETROSPECTIVE STUDY OF EVEROLIMUS WITH FULVESTRANT IN POSTMENOPAUSAL WOMEN WITH HORMONE RECEPTOR-POSITIVE METASTATIC BREAST CANCER PRETREATED WITH AROMATASE INHIBITORS(AI'S) AND SELECTIVE ESTROGEN MODIFIERS
|
Vanacker, Leen
|
|
2015
|
24 |
S3 |
p. S51-
1 p.
|
artikel
|
| 158 |
PR124 RUMINATION AND CANCER DISEASE: A CROSS-SECTIONAL STUDY IN A COHORT OF PATIENTS WITH BREAST AND LUNG CANCER
|
Riva, Silvia
|
|
2015
|
24 |
S3 |
p. S64-
1 p.
|
artikel
|
| 159 |
PR119 SENSITIZING PRIMARY HEALTHCARE WORKERS TOWARDS PSYCHOSOCIAL ISSUES OF BREAST-CANCER PATIENTS
|
Pramod, S.
|
|
2015
|
24 |
S3 |
p. S62-S63
2 p.
|
artikel
|
| 160 |
PR125 SOME PATTERNS OF BREAST CANCER EPIDEMIOLOGY
|
Ninashvili, Nanuli
|
|
2015
|
24 |
S3 |
p. S64-
1 p.
|
artikel
|
| 161 |
PR102 STERNAL RECURRENCE IN TREATED PATIENTS OF ADVANCED STAGE CARCINOMA BREAST - AN EMERGING ENTITY
|
Kumar, Divyesh
|
|
2015
|
24 |
S3 |
p. S56-S57
2 p.
|
artikel
|
| 162 |
PR111 SURGICAL TREATMENT OF ADVANCED BREAST CANCER. URGENCY OF THE PROBLEM
|
Myasnyankin, Michail J.
|
|
2015
|
24 |
S3 |
p. S60-
1 p.
|
artikel
|
| 163 |
PR121 TELEPHONIC COMMUNICATION IN PALLIATIVE CARE FOR BETTER MANAGEMENT OF TERMINAL CANCER PATIENTS IN RURAL INDIA AN NGO BASED APPROACH
|
Manna, Aditya
|
|
2015
|
24 |
S3 |
p. S63-
1 p.
|
artikel
|
| 164 |
PR93 THE CHANGES OF PLATELET-LYMPHOCYTE RATIO AS A SENSITIVE TUMOR MARKER TO PREDICT PROGRESSION IN METASTATIC BREAST CANCER
|
Kashiwaba, Masahiro
|
|
2015
|
24 |
S3 |
p. S53-
1 p.
|
artikel
|
| 165 |
PR94 TUMOR MARKER (CA 15-3) MONITORING FAILED TO DETECT DISEASE RELAPSE AND TRIGGERED UNNECESSARY PROCEDURES – REPORT OF TWO CASES
|
Bilic, Ivan
|
|
2015
|
24 |
S3 |
p. S54-
1 p.
|
artikel
|
| 166 |
PR153 VITAMIN D IMPORTANCE IN THE ONCOLOGY CONSULTATION FOR THE BREAST CANCER PATIENT
|
Fonseca, Vasco
|
|
2015
|
24 |
S3 |
p. S74-
1 p.
|
artikel
|
| 167 |
Sponsored satellite symposia
|
|
|
2015
|
24 |
S3 |
p. S14-S15
2 p.
|
artikel
|
| 168 |
Sponsors (as of September 2015)
|
|
|
2015
|
24 |
S3 |
p. S5-
1 p.
|
artikel
|
| 169 |
Welcome
|
Cardoso, Fatima
|
|
2015
|
24 |
S3 |
p. S1-
1 p.
|
artikel
|
Tijdschrift beschrijving